A novel PTEN-dependent link to ubiquitination controls FLIPS stability and TRAIL sensitivity in glioblastoma

Amith Panner1, Courtney A Crane, Changjiang Weng

  • 1Brain Tumor Research Center, Department of Neurological Surgery and University of California San Francisco Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94158-9001, USA.

Cancer Research
|October 8, 2009
PubMed

Insights

Loss of PTEN in glioblastoma activates Akt, stabilizing the anti-apoptotic protein FLIP(S) via the E3 ligase AIP4. This PTEN-Akt-AIP4 pathway regulates FLIP(S) stability and TRAIL resistance in GBM.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • Loss of Phosphatase and tensin homologue (PTEN) and activation of the Akt-mammalian target of rapamycin (mTOR) pathway promote glioblastoma multiforme (GBM) growth and resistance to apoptosis.
  • The anti-apoptotic protein FLIP(S) plays a crucial role in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis resistance in GBM.
  • PTEN deficiency in GBM cells leads to increased FLIP(S) half-life and decreased polyubiquitination, suggesting a link to protein stability.

Purpose of the Study:

  • To investigate the novel, mTOR-independent mechanism linking PTEN status to the ubiquitin-dependent control of FLIP(S) protein stability.
  • To elucidate the role of the E3 ubiquitin ligase atrophin-interacting protein 4 (AIP4) in regulating FLIP(S) stability and TRAIL sensitivity in PTEN-mutant GBM.
  • To define the PTEN-Akt-AIP4 pathway's contribution to TRAIL resistance in glioblastoma.

Main Methods:

  • Comparative analysis of FLIP(S) half-life and ubiquitination in PTEN wild-type (WT) and PTEN-mutant GBM cells.
  • Treatment of PTEN mutant GBM cells with Akt inhibitor and rapamycin to assess effects on FLIP(S) half-life.
  • Assessment of AIP4 levels, ubiquitination status, and association with FLIP(S) in different PTEN contexts.
  • Small interfering RNA (siRNA)-mediated suppression of AIP4 in PTEN WT cells.
  • Analysis of Akt activation effects on AIP4 ubiquitination and FLIP(S) levels and ubiquitination.

Main Results:

  • PTEN-deficient GBM cells exhibit a longer FLIP(S) half-life due to decreased FLIP(S) polyubiquitination, an effect partially reversed by Akt inhibition.
  • AIP4 levels are comparable, but AIP4 ubiquitination and association with FLIP(S) are altered in PTEN-deficient cells, with stable polyubiquitinated AIP4 showing reduced binding.
  • AIP4 suppression in PTEN WT cells mimics PTEN deficiency by increasing FLIP(S) half-life and TRAIL resistance.
  • Akt activation increases AIP4 ubiquitination, leading to suppressed FLIP(S) ubiquitination and increased FLIP(S) levels, thereby enhancing TRAIL resistance.

Conclusions:

  • The PTEN-Akt-AIP4 signaling axis is a critical regulator of FLIP(S) ubiquitination and stability.
  • This pathway significantly influences TRAIL-induced apoptosis sensitivity in glioblastoma multiforme.
  • A novel link between PTEN status and ubiquitin-mediated control of protein stability is established, impacting GBM pathogenesis.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated assembly and...